Mackenzie Financial Corp Bioventus Inc. Transaction History
Mackenzie Financial Corp
- $77.1 Billion
- Q3 2025
Shares
3 transactions
Others Institutions Holding BVS
# of Institutions
146Shares Held
50.1MCall Options Held
42.5KPut Options Held
100K-
Essex Woodlands Management, Inc. The Woodlands, TX13MShares$95.7 Million28.43% of portfolio
-
Juniper Investment Company, LLC New York, NY6.94MShares$51 Million18.87% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT5.81MShares$42.7 Million1.58% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.92MShares$21.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.37MShares$17.4 Million0.0% of portfolio
About Bioventus Inc.
- Ticker BVS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 61,664,200
- Market Cap $453M
- Description
- Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral ner...